Genome informatics company Cypher Genomics, Inc. will use its diagnostics technology to assist Celgene in discovering novel genomic biomarkers that identify patients who respond well to specific drugs. The collaboration comes during industry’s push in increasing efforts in precision medicine, tailoring therapy based on a patient’s genetic makeup. The companies announced …